Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
ProAssurance Corporation is a specialty property and casualty insurer focused primarily on professional liability insurance for healthcare providers, including physicians, dentists, and healthcare facilities across the United States. The company operates through four segments: Specialty P&C (medical professional liability), Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance, and Lloyd's Syndicates, with medical malpractice representing the core franchise. The stock trades at modest valuations reflecting a mature, low-growth specialty insurance franchise with recent profitability improvements driving the 67% one-year return.
ProAssurance generates revenue through underwriting premiums on specialty insurance policies and investment income from float. The medical professional liability business benefits from high barriers to entry due to specialized underwriting expertise, actuarial complexity, and long-tail claims requiring deep reserves management. Pricing power derives from physician-specific risk assessment capabilities and state-level regulatory relationships. The company earns underwriting profit when combined ratios stay below 100% (premiums exceed losses plus expenses) and generates additional returns by investing policyholder float in investment-grade fixed income securities. Competitive advantages include decades of medical malpractice claims data, established distribution relationships with physician groups and hospitals, and expertise in tail coverage (policies covering prior acts when physicians switch carriers).
Combined ratio performance (loss ratio plus expense ratio) - target sub-95% for profitability
Medical malpractice premium rate changes and renewal retention rates in key states (Florida, Texas, Pennsylvania)
Prior year reserve development (favorable or adverse) impacting reported earnings
Investment portfolio yield and duration positioning relative to interest rate movements
Healthcare litigation trends and tort reform legislation at state level affecting claims frequency/severity
Physician supply dynamics and shift toward employed physician models reducing individual policy demand as hospital systems self-insure or use captive structures
Telemedicine expansion and AI-assisted diagnostics potentially altering malpractice risk profiles and claims patterns in unpredictable ways
State-level tort reform erosion or plaintiff-friendly legal precedents increasing loss severity in key markets
Medicare reimbursement pressures forcing physician practice consolidation and reducing addressable market for individual policies
Competition from physician-owned mutual insurers (The Doctors Company, Medical Protective) with lower cost structures and policyholder dividend models
Larger multi-line carriers (Berkshire Hathaway, Chubb) entering medical malpractice with balance sheet advantages and cross-selling capabilities
Alternative risk transfer mechanisms including captives, risk retention groups, and self-insurance trusts eroding traditional insurance market share
Long-tail reserve adequacy risk - medical malpractice claims can take 5-10 years to settle, requiring accurate actuarial assumptions about future loss development and legal cost inflation
Investment portfolio duration mismatch if interest rates rise rapidly, creating unrealized losses that pressure statutory capital ratios and regulatory risk-based capital requirements
Modest debt/equity of 0.33x provides financial flexibility but any material adverse reserve development could pressure credit metrics and limit capital return capacity
low - Medical professional liability insurance is non-discretionary for practicing physicians due to state licensing requirements and hospital credentialing mandates, making demand highly inelastic to economic cycles. Workers' compensation premiums correlate moderately with employment levels and payroll, providing some cyclical exposure. Overall revenue is relatively recession-resistant, though investment income fluctuates with market conditions. Claims severity can increase during economic stress if juries award larger settlements.
Rising interest rates are highly positive for ProAssurance's business model. The company holds $3.5-4.0B in fixed income investments with estimated duration of 4-5 years, generating reinvestment opportunities at higher yields as bonds mature. A 100bp rate increase could add $35-40M annually to investment income over 3-4 years. Higher rates also increase discount rates applied to long-tail loss reserves, potentially releasing capital. However, rising rates compress book value multiples for insurance stocks and create mark-to-market losses on existing bond holdings (though held-to-maturity accounting mitigates P&L impact). Net effect is fundamentally positive but valuation-negative in rising rate environments.
Moderate credit exposure through investment portfolio composition. The company holds primarily investment-grade corporate bonds and municipal securities, with estimated 85-90% rated A or better. Credit spread widening creates mark-to-market losses and potential impairments. Minimal direct lending or credit underwriting exposure. Reinsurance counterparty credit risk exists but is managed through highly-rated reinsurers.
value - The stock trades at 1.0x book value and 1.1x sales with 2.7% ROE, attracting value investors seeking turnaround stories in specialty insurance. The 67% one-year return suggests momentum investors have participated in the profitability recovery, but low single-digit ROE and minimal growth limit appeal to growth-oriented funds. Modest dividend yield (estimated 2-3%) provides some income component. The institutional investor base likely includes insurance-specialist funds and deep-value managers willing to underwrite underwriting improvement thesis.
moderate - Specialty insurance stocks typically exhibit beta of 0.7-0.9 to broader markets with volatility driven by quarterly earnings surprises from reserve development and catastrophic losses. ProAssurance's focus on medical malpractice (lower catastrophe exposure than property insurers) reduces event-driven volatility, but quarterly combined ratio swings of 5-10 points create earnings unpredictability. The 66.8% one-year return suggests recent elevated volatility as the market repriced profitability improvements.
